ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Pitot Named New NCAB Chairman

May 4, 1979

House Subcommittee Passes Bush Request for NIH, NCI Budgets.

June 9, 2006

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

May 25, 2001

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

Screening Mammograms In Young Women Have Low Accuracy, Detect Few Cancers

May 28, 2010

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012